AUTL
Autolus Therapeutics plc
Next earnings Aug 10, 2026 · consensus $-0.24 EPS, $30.8M rev
Last earnings -7.0% on 2026-05-14
$1.59
▼ -4.22%$1.59▼ -21.67%
over 1Y
L $1.21EODHDH $2.68
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-4.2%
1W+3.9%
1M-5.4%
3M+19.5%
YTD-15.0%
1Y-21.7%
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 17 analysts
Buy
Revenue grew 644.9% YoY; but unprofitable (net margin -381.4%).
Autolus Therapeutics plc shows $75.4M in FY2025 revenue (+644.9% YoY), a -381.4% net margin, and -161.4% ROE.
Sources: SEC EDGAR (CIK 0001730463, latest 10-Q filed 2026-05-14) · EODHD · as of 6/24/2026, 11:00:22 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.